Original articleDesign and synthesis of novel 2-(4-(2-(dimethylamino)ethyl)-4H-1,2,4-triazol-3-yl)pyridines as potential antitumor agents

Add time:08/24/2019    Source:sciencedirect.com

New 2-(4-(2-(dimethylamino)ethyl)-4H-1,2,4-triazol-3-yl)pyridine derivatives were synthesized and evaluated for their in vitro cytotoxicity against five cancer cell lines namely MKN-45, H460, HT-29, A549 and U87MG, as well as the normal cell line WI-38. Nearly all the compounds exhibited superior potency to sorafenib with a better selectivity towards the MKN-45, H460 and HT-29 cell lines. In addition, the enzymatic screening result demonstrated that the optimized compounds possessed potent Raf kinase inhibition as well as favorable enzyme selectivity. The most promising compound, 11f, showed high levels of cytotoxicity against MKN-45, H460 and HT-29 cells with IC50 values of 51, 72 and 130 nM, respectively, which are 45.5, 30.4 and 27.8 folds higher than the corresponding IC50 values for sorafenib against these cell lines. Structure–activity relationships revealed that the dimethylaminoethyl group was crucial for high activity.

We also recommend Trading Suppliers and Manufacturers of ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate (cas 17243-69-5). Pls Click Website Link as below: cas 17243-69-5 suppliers

Prev:Studies on the metabolism and toxicological detection of the amphetamine-like anorectic mefenorex (cas 17243-57-1) in human urine by gas chromatography–mass spectrometry and fluorescence polarization immunoassay1
Next:Suppression of spike-wave discharge activity and c-fos expression by 2-methyl-4-oxo-3H-quinazoline-3-acetyl piperidine (Q5) in vivo)